Cartesian Therapeutics Inc (RNAC)
Deferred Revenue
$0.00
Quarterly · Period ending: · USD
RNAC Deferred Revenue
Latest reported$0.00period ending
Latest reported$0.00period ending
RNAC Quarterly Deferred Revenue ($1.31M → $0.00)
Quarterly deferred revenue
High-resolution chart · PNG
RNAC deferred revenue history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Deferred Revenue (USD) |
|---|---|
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 412,000 | |
| 2,311,000 | |
| 4,140,000 | |
| 4,234,000 | |
| 4,232,000 | |
| 593,000 | |
| 3,820,000 | |
| 15,974,000 | |
| 27,990,000 | |
| 53,883,000 | |
| 62,315,000 | |
| 75,013,000 | |
| 75,764,000 | |
| 72,050,000 | |
| 64,373,000 | |
| 1,928,000 | |
| 1,674,000 | |
| 1,674,000 | |
| 1,023,000 | |
| 1,023,000 | |
| 959,000 | |
| 959,000 | |
| 1,863,000 | |
| 2,012,000 | |
| 959,000 | |
| 787,000 | |
| 3,256,000 | |
| 2,566,000 | |
| 1,947,000 | |
| 1,836,000 | |
| 1,041,000 | |
| 1,242,000 | |
| 1,219,000 | |
| 1,313,000 |